After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.
Rezensionen / Stimmen
From the book reviews:
"Devoted to the rare or unusual subtypes of non-Hodgkin's lymphoma (NHL), this book provides a comprehensive review of each subtype, including its natural history, pathogenesis, molecular biology, prognosis, management, and future directions. . The intended audience includes hematologists, oncologists, pathologists, established researchers, medical students, and residents, but the book is probably most useful for hematologists, oncologists, and pathologists. . It is a keeper, especially for those interested in lymphoma." (Auayporn Nademanee, Doody's Book Reviews, August, 2014)
